What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His main research concerns Cancer research, Nanotechnology, Drug delivery, Nanoparticle and Biochemistry.
His specific area of interest is Cancer research, where Guangjun Nie studies Stromal cell.
His studies in Nanotechnology integrate themes in fields like Autophagy and Biophysics.
His studies deal with areas such as Plasma protein binding, Aptamer, DNA and Desmoplasia as well as Drug delivery.
His Nanoparticle study integrates concerns from other disciplines, such as Tumor response, Apatinib and Antiangiogenesis Therapy.
His study in the field of Antioxidant, Oxidative stress, Mitochondrion and Transferrin receptor is also linked to topics like MITOCHONDRIAL FERRITIN.
His most cited work include:
- A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. (753 citations)
- Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. (417 citations)
- A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo. (416 citations)
What are the main themes of his work throughout his whole career to date?
Guangjun Nie focuses on Cancer research, Drug delivery, Nanotechnology, Tumor microenvironment and In vivo.
His research integrates issues of Cancer cell, Cancer, Metastasis, Immunotherapy and Chemotherapy in his study of Cancer research.
His research in Drug delivery intersects with topics in Extracellular matrix, Pharmacology, Hepatic stellate cell and Doxorubicin.
Guangjun Nie combines subjects such as Biocompatibility and Biophysics with his study of Nanotechnology.
His Tumor microenvironment study deals with Peptide intersecting with Fibroblast activation protein, alpha.
His In vivo study incorporates themes from Adjuvant, Breast cancer, In vitro and Apoptosis.
He most often published in these fields:
- Cancer research (70.97%)
- Drug delivery (32.97%)
- Nanotechnology (18.64%)
What were the highlights of his more recent work (between 2019-2021)?
- Cancer research (70.97%)
- Drug delivery (32.97%)
- Tumor microenvironment (21.51%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cancer research, Drug delivery, Tumor microenvironment, Immunotherapy and Cancer immunotherapy.
His Cancer research study combines topics from a wide range of disciplines, such as Cancer, Metastasis, Antigen, Cytotoxic T cell and In vivo.
His Drug delivery research is multidisciplinary, relying on both Translation, microRNA and Genetic enhancement.
His study in Tumor microenvironment is interdisciplinary in nature, drawing from both Peptide, PD-L1, Antitumor immunity and Nanomedicine.
His Cancer immunotherapy study also includes
- Nanodevice which connect with Virology and DNA,
- Immune checkpoint which intersects with area such as T cell, Ectodomain and Peptide amphiphile.
His Immune system research incorporates elements of Extracellular matrix, Cell biology, Tumor initiation and Hepatic stellate cell.
Between 2019 and 2021, his most popular works were:
- Two-dimensional nanomaterials beyond graphene for antibacterial applications: current progress and future perspectives (28 citations)
- Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models (23 citations)
- Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models (23 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His primary areas of investigation include Cancer research, In vivo, Immunotherapy, Drug delivery and Cancer.
His Cancer research research includes themes of Therapeutic index, Doxorubicin, Toxicity, Cytotoxic T cell and Thrombin.
The various areas that Guangjun Nie examines in his In vivo study include Cisplatin, Apoptosis, K562 cells, Daunorubicin and Protein Corona.
His work deals with themes such as Tumor microenvironment, Blockade and Radiation therapy, which intersect with Immunotherapy.
The concepts of his Drug delivery study are interwoven with issues in Tumor stroma, Stromal cell, In vitro and Treatment efficacy.
His work on Immunosurveillance, Metastasis and Breast cancer is typically connected to Signal amplification as part of general Cancer study, connecting several disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
